Deutsche Bank
UTHR icon

Deutsche Bank’s United Therapeutics UTHR Stock Holding History

Deutsche Bank’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-300
Closed -$10K – 5806
2013
Q4 		$10K Hold
300
– – ﹤0.01% 4894
2013
Q3 		$2K Buy
+300
New +$21.9K ﹤0.01% 5341

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Deutsche Bank's UTHR Position: Q2 2026 in Review

Deutsche Bank reduced its United Therapeutics (UTHR) stake by 1.8% in Q2 2026, selling an estimated $1.98M and leaving 195,269 shares worth $106M. The position accounts for 0.03% of the portfolio, ranked #483.

Deutsche Bank first reported a position in UTHR in Q2 2013 and has held it in 53 quarters since. The position peaked at $322M in Q2 2015. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Deutsche Bank held 195,269 shares of United Therapeutics worth $106M as of Q2 2026.
  • Deutsche Bank sold 3,508 United Therapeutics shares in Q2 2026, an estimated $1.98M.
  • United Therapeutics made up 0.03% of Deutsche Bank's portfolio in Q2 2026, its #483 holding.
  • Deutsche Bank first reported a position in United Therapeutics in Q2 2013 and has held it in 53 quarters since.
  • Deutsche Bank's United Therapeutics position peaked at $322M in Q2 2015.
  • 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.